82124-9 |
Guidance for radiation treatment |
Find |
XXX |
Pt |
Doc |
US |
|
ACTIVE |
US Guidance for radiation treatment of Unspecified body region |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
RAD |
|
82124-9 |
|
US |
|
|
Both |
|
|
|
0 |
US Guided RT |
|
|
|
|
|
Document; Echography; Finding; Findings; Guid; Guide; Guided; Imaging; Misc; Miscellaneous; Other; Point in time; Radiology; Random; RT; Simulation; Sonogram; Sonograph; Sonography; Spec; To be specified in another part of the message; Tx; ULS; Ultrasound; Unspecified |
2.64 |
2.56 |
|
|
|
|
|
|
|
|
|
|
|
0 |
82125-6 |
Respiratory pathogens DNA & RNA tested for |
Prid |
Plr fld |
Pt |
Nom |
Probe.amp.tar |
|
ACTIVE |
Respiratory pathogens DNA and RNA tested for in Pleural fluid by NAA with probe detection |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
82125-6 |
|
Probe.amp.tar |
|
|
Observation |
|
|
|
0 |
Resp path DNA+RNA Tested Plr NAA+probe |
|
|
|
|
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Identity or presence; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Lung; Microbiology; NAA+probe; NAAT; NASBA; Nominal; Nucleic acid sequence based analysis; PCR; Pleural; Pleural fluid; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; Pulmonary; Pulmonology; QBR; Random; Resp path DNA+; Resp path DNA+RNA; Resp path DNA+RNA tst; Resp pathogens; Respiratory; Respiratory bacteria & viruses; Respiratory bacteria & viruses DNA & RNA; Ribonucleic acid; SDA; Strand Displacement Amplification; thoracentesis fluid; TMA; Transcription mediated amplification |
2.63 |
2.56 |
|
|
|
|
|
|
|
|
|
|
Changed "bacteria and viruses" in Component to "pathogens" for naming consistency across terms. |
0 |
82126-4 |
Guidance for radiation treatment |
Find |
XXX |
Pt |
Doc |
PT |
|
ACTIVE |
PT Guidance for radiation treatment of Unspecified body region |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
RAD |
|
82126-4 |
|
PT |
|
|
Both |
|
|
|
0 |
PT Guided RT |
|
|
|
|
|
Document; Finding; Findings; Guid; Guide; Guided; Imaging; Misc; Miscellaneous; Other; PET Scan; Point in time; Position Emmision Tomography; Positron Emission Tomography; Rad; RADIOLOGY; Radnuc.PET; Random; RT; Simulation; Spec; To be specified in another part of the message; Tx; Unspecified |
2.64 |
2.56 |
|
|
|
|
|
|
|
|
|
|
|
0 |
82127-2 |
Respiratory pathogens DNA & RNA |
Prid |
Plr fld |
Pt |
Nom |
Probe.amp.tar |
|
ACTIVE |
Respiratory pathogens DNA and RNA [Identifier] in Pleural fluid by NAA with probe detection |
|
NAM |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
82127-2 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
Resp path DNA+ RNA Plr NAA+probe |
|
|
|
|
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Identity or presence; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Lung; Microbiology; NAA+probe; NAAT; NASBA; Nominal; Nucleic acid sequence based analysis; PCR; Pleural; Pleural fluid; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; Pulmonary; Pulmonology; QBR; Random; Resp path DNA+; Resp path DNA+RNA; Resp pathogens; Respiratory; Respiratory bacteria & viruses; Respiratory bacteria & viruses DNA & RNA; Ribonucleic acid; SDA; Strand Displacement Amplification; thoracentesis fluid; TMA; Transcription mediated amplification |
2.79 |
2.56 |
|
|
|
|
|
|
|
|
|
|
Release 2.79: COMPONENT: Triggered by the coll w SCT:The understanding is that the word "identified" refers to the property "PRID", its presence in the component is redundant to the property. Therefore it is better to remove "identified" from the component.; Previous Releases: Changed "bacteria and viruses" in Component to "pathogens" for naming consistency across terms. |
0 |
82128-0 |
Multisection^WO contrast |
Find |
Head>Brain+Face |
Pt |
Doc |
MR |
|
ACTIVE |
MR Brain and Face WO contrast |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
RAD |
|
82128-0 |
|
MR |
|
|
Both |
|
|
|
0 |
MR Brain+Face WO contr |
|
|
|
|
|
Brain; c; Cerebral; Cerebrum; Contr; Contra; Contrst; Cranial; Cranium; Document; Finding; Findings; Head; Imaging; Intracranial; Mitral regurgitation maximum velocity; MRI; Point in time; Rad; RADIOLOGY; Random; Skull; without contrast |
2.61 |
2.56 |
|
|
|
|
|
|
|
|
|
|
|
0 |
82129-8 |
Multisection^WO & W contrast IV |
Find |
Head>Brain+Face |
Pt |
Doc |
MR |
|
ACTIVE |
MR Brain and Face WO and W contrast IV |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
RAD |
|
82129-8 |
|
MR |
|
|
Both |
|
|
|
0 |
MR Brain+Face WO+W contr IV |
|
|
|
|
|
Brain; c; Cerebral; Cerebrum; Contr; Contra; Contrst; Cranial; Cranium; Document; Finding; Findings; Head; Imaging; Intracranial; Mitral regurgitation maximum velocity; MRI; Point in time; Rad; RADIOLOGY; Random; Skull; W contr IV; WC; WO & WC; WO+W contr; WO+W contr IV; WWO |
2.61 |
2.56 |
|
|
|
|
|
|
|
|
|
|
|
0 |
8213-1 |
Opiates |
MCnc |
Meconium |
Pt |
Qn |
|
|
DISCOURAGED |
Opiates [Mass/volume] in Meconium |
|
MIN |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
DRUG/TOX |
|
8213-1 |
|
|
|
|
Both |
|
|
|
0 |
Opiates Mec-mCnc |
|
|
|
Y |
|
Addiction; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Heroin; Illicit; Level; Mass concentration; Mec; OP; Opi; Opiate; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random |
2.73 |
1.0h(2) |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
82130-6 |
Multisection^WO contrast |
Find |
Head>Face & Neck |
Pt |
Doc |
MR |
|
ACTIVE |
MR Face and Neck WO contrast |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
RAD |
|
82130-6 |
|
MR |
|
|
Both |
|
|
|
0 |
MR Face+Neck WO contr |
|
|
|
|
|
Brain; c; Contr; Contra; Contrst; Cranial; Cranium; Document; Face+Neck; Finding; Findings; Imaging; Intracranial; Mitral regurgitation maximum velocity; MRI; Point in time; Rad; RADIOLOGY; Random; Skull; without contrast |
2.61 |
2.56 |
|
|
|
|
|
|
|
|
|
|
Updated System from "Head+Neck>Face" to clarify that the face and neck are being imaged according to the LOINC/RadLex unified model. |
0 |
82131-4 |
Multisection^WO & W contrast IV |
Find |
Head>Face & Neck |
Pt |
Doc |
MR |
|
ACTIVE |
MR Face and Neck WO and W contrast IV |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
RAD |
|
82131-4 |
|
MR |
|
|
Both |
|
|
|
0 |
MR Face+Neck WO+W contr IV |
|
|
|
|
|
Brain; c; Contr; Contra; Contrst; Cranial; Cranium; Document; Face+Neck; Finding; Findings; Imaging; Intracranial; Mitral regurgitation maximum velocity; MRI; Point in time; Rad; RADIOLOGY; Random; Skull; W contr IV; WC; WO & WC; WO+W contr; WO+W contr IV; WWO |
2.61 |
2.56 |
|
|
|
|
|
|
|
|
|
|
Updated System from "Head+Neck>Face" to clarify that the face and neck are being imaged according to the LOINC/RadLex unified model. |
0 |
82132-2 |
Multisection^WO & W contrast IV |
Find |
Head>Face & Neck |
Pt |
Doc |
CT |
|
ACTIVE |
CT Face and Neck WO and W contrast IV |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
RAD |
|
82132-2 |
|
CT |
|
|
Both |
|
|
|
0 |
CT Face+Neck WO+W contr IV |
|
|
|
|
|
Brain; c; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; Cranial; Cranium; CT scan; Document; Face+Neck; Finding; Findings; Imaging; Intracranial; Point in time; Rad; RADIOLOGY; Random; Skull; W contr IV; WC; WO & WC; WO+W contr; WO+W contr IV; WWO |
2.61 |
2.56 |
|
|
|
|
|
|
|
|
|
|
Updated System from "Head+Neck>Face" to clarify that the face and neck are being imaged according to the LOINC/RadLex unified model. |
0 |
82133-0 |
Multisection^WO contrast |
Find |
Head>Face & Neck |
Pt |
Doc |
CT |
|
ACTIVE |
CT Face and Neck WO contrast |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
RAD |
|
82133-0 |
|
CT |
|
|
Both |
|
|
|
0 |
CT Face+Neck WO contr |
|
|
|
|
|
Brain; c; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; Cranial; Cranium; CT scan; Document; Face+Neck; Finding; Findings; Imaging; Intracranial; Point in time; Rad; RADIOLOGY; Random; Skull; without contrast |
2.61 |
2.56 |
|
|
|
|
|
|
|
|
|
|
Updated System from "Head+Neck>Face" to clarify that the face and neck are being imaged according to the LOINC/RadLex unified model. |
0 |
82134-8 |
Respiratory pathogens DNA & RNA tested for |
Prid |
Respiratory System Specimen |
Pt |
Nom |
Probe.amp.tar |
|
ACTIVE |
Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection |
|
MAJ |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
82134-8 |
|
Probe.amp.tar |
|
|
Observation |
|
|
|
0 |
Resp path DNA+RNA Tested Resp NAA+probe |
|
|
|
|
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Breathing; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Identity or presence; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Lung; Lungs; Microbiology; NAA+probe; NAAT; NASBA; Nominal; Nucleic acid sequence based analysis; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; Pulmonary; Pulmonology; QBR; Random; Resp path DNA+; Resp path DNA+RNA; Resp path DNA+RNA tst; Resp pathogens; Respiratory; Respiratory bacteria & viruses; Respiratory bacteria & viruses DNA & RNA; Ribonucleic acid; RS; SDA; Spec; Strand Displacement Amplification; TMA; Transcription mediated amplification |
2.75 |
2.56 |
|
|
|
|
|
|
|
|
|
|
Release 2.75: SYSTEM: There are 2 similar system's in LOINC: 1- Respiratory system 2- Respiratory specimen Due to an applied logic, the display in the System axis for 1 is Respiratory (adjective) without specification of sample, specimen, or other specific noun, while 2 is displayed fully as Respiratory specimen. Therefore for now we replaced 1 with Respiratory system specimen, which will affect 83 term. The result is replacing "Respiratory" with "Respiratory system specimen". This is the short approach. The bigger project is to potentially merge data that has either 1 or 2 together. This is a project to pass by the laboratory committee and will involve about 1500 concepts.; Previous Releases: Changed "bacteria and viruses" in Component to "pathogens" for naming consistency across terms. |
0 |
82135-5 |
Respiratory pathogens DNA & RNA tested for |
Prid |
Tissue |
Pt |
Nom |
Probe.amp.tar |
|
DEPRECATED |
Deprecated Respiratory pathogens DNA and RNA tested for in Tissue by Probe and target amplification method |
|
DEL |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
82135-5 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
Deprecated Resp path DNA+RNA Tested tiss |
|
|
|
|
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Identity or presence; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Lung; Microbiology; NAA+probe; NAAT; NASBA; Nominal; Nucleic acid sequence based analysis; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; Pulmonary; Pulmonology; QBR; Random; Resp path DNA+; Resp path DNA+RNA; Resp path DNA+RNA tst; Resp pathogens; Respiratory; Respiratory bacteria & viruses; Respiratory bacteria & viruses DNA & RNA; Ribonucleic acid; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification |
2.58 |
2.56 |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
82136-3 |
Views for tumor^W I-123 MIBG IV |
Find |
Whole body |
Pt |
Doc |
NM |
|
ACTIVE |
NM Whole body Views for tumor W I-123 MIBG IV |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
RAD |
|
82136-3 |
|
NM |
|
|
Both |
|
|
|
0 |
NM WB Vs tumor W I-123 MIBG IV |
|
|
|
|
|
123I; bod; Bodies; CorePlaybook; Document; Films; Finding; Findings; Imaging; Metaiodobenzylguanidine; Playbook; Point in time; Rad; Radiology; RAI; Random; Scan; View; VWS; WB |
2.64 |
2.56 |
|
|
|
|
|
|
|
|
|
|
|
0 |
82137-1 |
FGFR3 gene.p.Gly380Arg targeted mutation analysis |
Find |
Amnio fld/CVS |
Pt |
Doc |
Molgen |
|
ACTIVE |
FGFR3 gene p.Gly380Arg targeted mutation analysis in Amniotic fluid or Chorionic villus sample by Molecular genetics method |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MOLPATH.MUT |
|
82137-1 |
|
Molgen |
|
|
Both |
|
|
|
0 |
FGFR3 p.G380R Mut Anl Amn/CVS |
|
|
|
|
|
ACH; Achondroplasia; AF; Amn; Amn fl; Amn/CVS; Amnio; Amniotic flu; Amniotic fluid; CD333; CEK2; Chorionic villi; Chorionic villus sample; Document; FGFR3 Gly380Arg; FGFR3 p.G380R; fibroblast growth factor receptor 3; Finding; Findings; Genetics; Gyn; Gynecology; Heredity; Heritable; HSFGFR3EX; Inherited; JTK4; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mut Anl; Mutations; OB; ObGyn; Obstetrics; P prime; PCR; Point in time; Random; Thanatophoric dwarfism; Thanatophoric dysplasia |
2.65 |
2.56 |
|
|
|
|
|
|
|
|
|
|
|
0 |
82138-9 |
GJB2 gene.c.35delG targeted mutation analysis |
Find |
Bld/Tiss |
Pt |
Doc |
Molgen |
|
ACTIVE |
GJB2 gene c.35delG targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MOLPATH.MUT |
|
82138-9 |
|
Molgen |
|
|
Both |
|
|
|
0 |
GJB2 c.35delG Mut Anl Bld/T |
|
|
|
|
|
Blood; c.35deG; Connexin 26; Cx26; Deafness, autosomal dominant 3; Deafness, autosomal recessive 1; Deafness, autosomal recessive 3; Deafness, digenic; DFNA3; DFNA3A; DFNB1; DFNB1A; Document; Finding; Findings; Gap junction beta-2 protein gene; gap junction protein, beta 2, 26kDa; Genetics; GJB2 c.35delG; Heredity; Heritable; HID; Inherited; KID; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mut Anl; Mutations; NSRD1; PCR; Point in time; PPK; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue |
2.65 |
2.56 |
|
|
|
|
|
|
|
|
|
|
|
0 |
82139-7 |
LRRK2 gene.p.Arg1441Gly & p.Gly2019Ser targeted mutation analysis |
Find |
Bld/Tiss |
Pt |
Doc |
Molgen |
|
ACTIVE |
LRRK2 gene Arg1441Gly and Gly2019Ser targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MOLPATH.MUT |
|
82139-7 |
|
Molgen |
|
|
Both |
|
|
|
0 |
LRRK2 p.R1441G+p.G2019S Mut Anl Bld/T |
|
|
|
|
|
AURA17; Blood; Dardarin; Document; Finding; Findings; Genetics; Heredity; Heritable; Inherited; leucine-rich repeat kinase 2; LRRK2 p.R1441G+p.G2019S; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mut Anl; Mutations; P prime; PARK8; Parkinson disease; PCR; Point in time; Random; RIPK7; ROCO2; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue |
2.65 |
2.56 |
|
|
|
|
|
|
|
|
|
|
|
0 |
8214-9 |
Opiates |
PrThr |
Meconium |
Pt |
Ord |
|
|
ACTIVE |
Opiates [Presence] in Meconium |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
8214-9 |
|
|
|
|
Both |
|
|
|
0 |
Opiates Mec Ql |
|
|
|
|
|
Addiction; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Heroin; Illicit; Mec; OP; Opi; Opiate; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen; UniversalLabOrders |
2.73 |
1.0h(2) |
|
|
|
|
|
|
|
|
|
|
The Property has been changed from ACnc to reflect the new model for ordinal terms where results are based on a cut-off value.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
82140-5 |
MYD88 gene.p.Leu265Pro targeted mutation analysis |
Find |
Bld/Tiss |
Pt |
Doc |
Molgen |
|
ACTIVE |
MYD88 gene p.Leu265Pro targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MOLPATH.MUT |
|
82140-5 |
|
Molgen |
|
|
Both |
|
|
|
0 |
MYD88 L265P Mut Anl Bld/T |
|
|
|
|
|
Blood; Document; Finding; Findings; Genetics; Heredity; Heritable; IgM monoclonal gammopathy of undetermined significance; IgM-MGUS; Inherited; L265P; LPL; Lymphoplasmacytic lymphoma; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Monoclonal Gammapathies; Mut; Mut Anl; Mutations; MyD88 deficiency; MYD88 L265P; myeloid differentiation primary response protein MyD88; P prime; p.Leu265Pro; PCR; Point in time; Random; Tissue; Tissue, unspecified; Waldenstroms Macroglobulinemia; Waldenstrom's Macroglobulinemia; WB; Whole blood; Whole blood or Tissue |
2.73 |
2.56 |
|
|
|
|
|
|
|
|
|
|
|
0 |
82141-3 |
Did you live with anyone who was depressed, mentally ill, or suicidal^pre 18Yo |
Find |
^Patient |
Pt |
Ord |
ACE.BRFSS |
|
ACTIVE |
Did you live with anyone who was depressed, mentally ill, or suicidal--before 18 years old [ACE.BRFSS] |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SURVEY.MTLHLTH |
|
82141-3 |
|
ACE.BRFSS |
|
|
Observation |
|
|
|
0 |
|
|
ACE_BRFSS.Q1 |
Did you live with anyone who was depressed, mentally ill, or suicidal? |
|
|
Adverse Childhood Experiences; Before; Finding; Findings; Lived w mentally ill; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MTLHLTH; World Heatlth Organization |
2.61 |
2.56 |
|
|
|
|
|
|
|
|
|
|
Changed TIME to Pt and added CHALLENGE ^pre 18Yo to better represent questions about before patient turned 18 |
0 |
82142-1 |
Did you live with anyone who was a problem drinker or alcoholic^pre 18Yo |
Find |
^Patient |
Pt |
Ord |
ACE.BRFSS |
|
ACTIVE |
Did you live with anyone who was a problem drinker or alcoholic--before 18 years old [ACE.BRFSS] |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SURVEY.MTLHLTH |
|
82142-1 |
|
ACE.BRFSS |
|
|
Observation |
|
|
|
0 |
|
|
ACE_BRFSS.Q2 |
Did you live with anyone who was a problem drinker or an alcoholic? |
|
|
Adverse Childhood Experiences; Before; Finding; Findings; Lived w alcoholic; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MTLHLTH; World Heatlth Organization |
2.61 |
2.56 |
|
|
|
|
|
|
|
|
|
|
Changed TIME to Pt and added CHALLENGE ^pre 18Yo to better represent questions about before patient turned 18 |
0 |
82143-9 |
Did you live with anyone who used illegal street drugs or who abused prescription medications^pre 18Yo |
Find |
^Patient |
Pt |
Ord |
ACE.BRFSS |
|
ACTIVE |
Did you live with anyone who used illegal street drugs or who abused prescription medications--before 18 years old [ACE.BRFSS] |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SURVEY.MTLHLTH |
|
82143-9 |
|
ACE.BRFSS |
|
|
Observation |
|
|
|
0 |
|
|
ACE_BRFSS.Q3 |
Did you live with anyone who used illegal street drugs or who abused prescription medications? |
|
|
Adverse Childhood Experiences; Before; Drug; Finding; Findings; Lived w drug abuser; Ordinal; Point in time; QL; Qual; Qualitative; Random; Rx; Screen; Survey; SURVEY.MTLHLTH; World Heatlth Organization |
2.61 |
2.56 |
|
|
|
|
|
|
|
|
|
|
Changed TIME to Pt and added CHALLENGE ^pre 18Yo to better represent questions about before patient turned 18 |
0 |
82144-7 |
Did you live with anyone who served time or was sentenced to serve time in a prison, jail, or other correctional facility^pre 18Yo |
Find |
^Patient |
Pt |
Ord |
ACE.BRFSS |
|
ACTIVE |
Did you live with anyone who served time or was sentenced to serve time in a prison, jail, or other correctional facility--before 18 years old [ACE.BRFSS] |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SURVEY.MTLHLTH |
|
82144-7 |
|
ACE.BRFSS |
|
|
Observation |
|
|
|
0 |
|
|
ACE_BRFSS.Q4 |
Did you live with anyone who served time or was sentenced to serve time in a prison, jail, or other correctional facility? |
|
|
Adverse Childhood Experiences; Before; Finding; Findings; Lived w person who served time; Ordinal; Othr; Point in time; QL; Qual; Qualitative; Random; Screen; SDOH; Survey; SURVEY.MTLHLTH; World Heatlth Organization |
2.61 |
2.56 |
|
|
|
|
|
|
|
|
|
|
Changed TIME to Pt and added CHALLENGE ^pre 18Yo to better represent questions about before patient turned 18 |
0 |
82145-4 |
Were your parents separated or divorced^pre 18Yo |
Find |
^Patient |
Pt |
Nom |
ACE.BRFSS |
|
ACTIVE |
Were your parents separated or divorced--before 18 years old [ACE.BRFSS] |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SURVEY.MTLHLTH |
|
82145-4 |
|
ACE.BRFSS |
|
|
Observation |
|
|
|
0 |
|
|
ACE_BRFSS.Q5 |
Were your parents ever separated or divorced? |
|
|
Adverse Childhood Experiences; Before; Finding; Findings; Nominal; Parents divorced; Point in time; Random; Survey; SURVEY.MTLHLTH |
2.61 |
2.56 |
|
|
|
|
|
|
|
|
|
|
Changed TIME to Pt and added CHALLENGE ^pre 18Yo to better represent questions about before patient turned 18 |
0 |
82146-2 |
How often did your parents or adults in your home ever slap, hit, kick, punch or beat each other up^pre 18Yo |
Find |
^Patient |
Pt |
Ord |
ACE.BRFSS |
|
ACTIVE |
How often did your parents or adults in your home ever slap, hit, kick, punch or beat each other up--before 18 years old [ACE.BRFSS] |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SURVEY.MTLHLTH |
|
82146-2 |
|
ACE.BRFSS |
|
|
Observation |
|
|
|
0 |
|
|
ACE_BRFSS.Q6 |
How often did you parents or adults in your home ever slap, hit, kick, punch or beat each other up? |
|
|
Adverse Childhood Experiences; Before; Finding; Findings; Ordinal; Othr; Parents abused each other; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MTLHLTH |
2.61 |
2.56 |
|
|
|
|
|
|
|
|
|
|
Changed TIME to Pt and added CHALLENGE ^pre 18Yo to better represent questions about before patient turned 18 |
0 |